AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 47 filers reported holding AGILE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $116,000 | +346.2% | 237,642 | +771.4% | 0.01% | +500.0% |
Q3 2021 | $26,000 | +52.9% | 27,272 | +109.8% | 0.00% | 0.0% |
Q2 2021 | $17,000 | -64.6% | 13,000 | -21.6% | 0.00% | -60.0% |
Q4 2020 | $48,000 | -79.2% | 16,588 | -78.2% | 0.01% | -87.5% |
Q3 2020 | $231,000 | +413.3% | 76,129 | +323.4% | 0.04% | +900.0% |
Q4 2019 | $45,000 | -48.9% | 17,979 | -69.2% | 0.00% | -20.0% |
Q1 2019 | $88,000 | +183.9% | 58,404 | +9.3% | 0.01% | +150.0% |
Q4 2018 | $31,000 | -3.1% | 53,447 | -38.3% | 0.00% | 0.0% |
Q3 2018 | $32,000 | +190.9% | 86,588 | +281.3% | 0.00% | – |
Q2 2018 | $11,000 | -85.5% | 22,706 | -23.2% | 0.00% | -100.0% |
Q1 2018 | $76,000 | -67.2% | 29,584 | -65.7% | 0.00% | -66.7% |
Q4 2017 | $232,000 | -38.0% | 86,316 | +3.0% | 0.01% | -36.8% |
Q3 2017 | $374,000 | – | 83,806 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |